News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,450 Results
Type
Article (40501)
Company Profile (290)
Press Release (652659)
Section
Business (205450)
Career Advice (2042)
Deals (35559)
Drug Delivery (87)
Drug Development (81768)
Employer Resources (168)
FDA (16372)
Job Trends (14963)
News (347961)
Policy (33083)
Tag
Academia (2597)
Alliances (49644)
Alzheimer's disease (1238)
Approvals (16294)
Artificial intelligence (127)
Bankruptcy (353)
Best Places to Work (11667)
Biotechnology (207)
Breast cancer (119)
Cancer (1052)
Cardiovascular disease (90)
Career advice (1705)
Cell therapy (226)
Clinical research (64901)
Collaboration (370)
Compensation (188)
COVID-19 (2567)
C-suite (89)
Data (1050)
Diabetes (151)
Diagnostics (6247)
Earnings (85147)
Employer resources (146)
Events (110487)
Executive appointments (283)
FDA (16881)
Funding (331)
Gene therapy (176)
GLP-1 (584)
Government (4401)
Healthcare (18983)
Infectious disease (2652)
Inflammatory bowel disease (105)
Interviews (325)
IPO (16344)
Job creations (3647)
Job search strategy (1453)
Layoffs (414)
Legal (7926)
Lung cancer (169)
Manufacturing (174)
Medical device (13400)
Medtech (13405)
Mergers & acquisitions (19274)
Metabolic disorders (395)
Neuroscience (1496)
NextGen Class of 2024 (6608)
Non-profit (4524)
Northern California (1416)
Obesity (229)
Opinion (186)
Patents (98)
People (56668)
Phase I (20092)
Phase II (28575)
Phase III (21358)
Pipeline (442)
Postmarket research (2613)
Preclinical (8540)
Radiopharmaceuticals (236)
Rare diseases (210)
Real estate (5957)
Regulatory (22018)
Research institute (2370)
Resumes & cover letters (353)
Southern California (1269)
Startups (3594)
United States (13131)
Vaccines (558)
Weight loss (168)
Date
Last 7 days (924)
Last 30 days (3436)
Last 365 days (35780)
2024 (32434)
2023 (40477)
2022 (51579)
2021 (56118)
2020 (54612)
2019 (47273)
2018 (35587)
2017 (32572)
2016 (31982)
2015 (38003)
2014 (31693)
2013 (26729)
2012 (28994)
2011 (29704)
2010 (27770)
Location
Africa (730)
Arizona (192)
Asia (37732)
Australia (6181)
California (3202)
Canada (1255)
China (238)
Colorado (143)
Connecticut (143)
Europe (81832)
Florida (440)
Georgia (112)
Illinois (339)
Indiana (192)
Kansas (96)
Maryland (574)
Massachusetts (2555)
Michigan (154)
Minnesota (272)
New Jersey (929)
New York (931)
North Carolina (704)
Northern California (1416)
Ohio (134)
Pennsylvania (816)
South America (1106)
Southern California (1269)
Texas (439)
Utah (89)
Washington State (355)
693,450 Results for "standard bariatrics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 20, 2024
Standard BioTools Inc. today announced that the Human Capital Committee of its Board of Directors, which is composed entirely of independent directors, granted an equity award effective as of May 20, 2024, under the Standard BioTools Inc. 2022 Inducement Equity Incentive Plan (Plan).
May 20, 2024
·
2 min read
Biotech Bay
Standard BioTools to Participate in Upcoming Investor Conferences
Standard BioTools Inc. (“Standard BioTools”) (Nasdaq:LAB) today announced that its management team will participate in the following investor conferences in the month of June.
May 22, 2024
·
2 min read
Policy
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced that it received a notice from the NYSE American LLC dated April 18, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards.
April 19, 2024
·
4 min read
Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) Announces Launch to Set New Standard in Life Sciences Commercialization Management Consulting
Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) is proud to announce its official launch, poised to set a new standard in life sciences consulting.
April 30, 2024
·
3 min read
Business
Standard BioTools Reports First Quarter 2024 Financial Results
Standard BioTools Inc. announced financial results for the first quarter ended March 31, 2024 and recent business updates.
May 8, 2024
·
19 min read
Press Releases
Standard BioTools to Participate in Upcoming Investor Conferences
October 31, 2024
·
1 min read
Press Releases
Standard BioTools Appoints Alex Kim as Chief Financial Officer
November 8, 2024
·
2 min read
Press Releases
Ansa Biotechnologies Sets New Standard in Long, Complex DNA
November 13, 2024
·
4 min read
BioMidwest
Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers
Standard BioTools Inc. announced that it has purchased the LSAXT system from Carterra®, a leading provider of high-throughput large and small molecule screening and characterization solutions.
May 28, 2024
·
6 min read
Biotech Bay
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the market.
April 25, 2024
·
2 min read
1 of 69,345
Next
